![Yuval Cabilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuval Cabilly
Directeur/Membre du Conseil chez
AYALA PHARMACEUTICALS, INC.
Profil
Dr. Yuval Cabilly is a Co- Founder and General Partner at Israel Biotech Fund.
He is on the Board of Directors at Ayala Pharmaceuticals, Inc., Biond Biologics Ltd., Pharma Two B Ltd., Ramot at Tel Aviv University Ltd. and Tau Ventures Ltd. Dr. Cabilly was previously employed as a Board Member by Tamarix Pharma Ltd. He received his undergraduate degree from Tel-Aviv University and a doctorate degree from Tel-Aviv University.
Postes actifs de Yuval Cabilly
| Sociétés | Poste | Début |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/10/2023 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Fondateur | 01/12/2014 |
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Directeur/Membre du Conseil | 01/09/2020 |
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Manufactures combination drugs for neurological disorders | Directeur/Membre du Conseil | 01/09/2020 |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Directeur/Membre du Conseil | 01/03/2021 |
Tau Ventures Ltd.
 Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yuval Cabilly
| Sociétés | Poste | Fin |
|---|---|---|
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Directeur/Membre du Conseil | - |
Formation de Yuval Cabilly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Commercial Services |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Manufactures combination drugs for neurological disorders | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Biond Biologics Ltd.
Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Health Technology |
Tau Ventures Ltd.
Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Finance |
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
Ayala Pharmaceuticals, Inc.
 Ayala Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops cancer therapeutics | Health Technology |
Choisissez Zonebourse 
